July 2017

XtalPi and AMRI’s SSCI Enter into Joint Research Agreement to Apply Computational Technologies to Solid-Form Pharmaceutical Research Challenges

  Boston, Mass., (July 21, 2017) –XtalPi Inc., a pharmaceutical technology company offering intelligent digital drug development solutions to empower more efficient pharmaceutical research, is joining forces with AMRI SSCI, LLC (SSCI), a division of Albany Molecular Research, Inc. (AMRI), to identify solid forms of small...

Read More